160 related articles for article (PubMed ID: 19875067)
41. Radiofrequency tissue ablation using cooled tip for liver metastases of endocrine tumors.
Hellman P; Ladjevardi S; Skogseid B; Akerström G; Elvin A
World J Surg; 2002 Aug; 26(8):1052-6. PubMed ID: 12016482
[TBL] [Abstract][Full Text] [Related]
42. CT-guided radiofrequency ablation in patients with hepatic metastases from breast cancer.
Jakobs TF; Hoffmann RT; Schrader A; Stemmler HJ; Trumm C; Lubienski A; Murthy R; Helmberger TK; Reiser MF
Cardiovasc Intervent Radiol; 2009 Jan; 32(1):38-46. PubMed ID: 18575933
[TBL] [Abstract][Full Text] [Related]
43. Hypertensive Crisis during Microwave Ablation of Adrenal Neoplasms: A Retrospective Analysis of Predictive Factors.
Zheng L; Zhou F; Yu X; Liang P; Cheng Z; Han Z; Yu J; Liu F; Wang W
J Vasc Interv Radiol; 2019 Sep; 30(9):1343-1350. PubMed ID: 31155498
[TBL] [Abstract][Full Text] [Related]
44. Breast cancer liver metastases: US-guided percutaneous radiofrequency ablation--intermediate and long-term survival rates.
Meloni MF; Andreano A; Laeseke PF; Livraghi T; Sironi S; Lee FT
Radiology; 2009 Dec; 253(3):861-9. PubMed ID: 19709994
[TBL] [Abstract][Full Text] [Related]
45. Retroperitoneoscopic-guided radiofrequency ablation of renal tumors.
Pautler SE; Pavlovich CP; Mikityansky I; Drachenberg DE; Choyke PL; Linehan WM; Wood BJ; Walther MM
Can J Urol; 2001 Aug; 8(4):1330-3. PubMed ID: 11564277
[TBL] [Abstract][Full Text] [Related]
46. Assessment of liver ablation using cone beam computed tomography.
Abdel-Rehim M; Ronot M; Sibert A; Vilgrain V
World J Gastroenterol; 2015 Jan; 21(2):517-24. PubMed ID: 25593467
[TBL] [Abstract][Full Text] [Related]
47. Surgical resection of multiple liver metastasis of functional malignant pheochromocytoma: a case report and literature review.
Wei S; Wu D; Yue J
J Cancer Res Ther; 2013 Nov; 9 Suppl():S183-5. PubMed ID: 24516058
[TBL] [Abstract][Full Text] [Related]
48. Microwave ablation of liver metastases to overcome the limitations of radiofrequency ablation.
Ierardi AM; Floridi C; Fontana F; Chini C; Giorlando F; Piacentino F; Brunese L; Pinotti G; Bacuzzi A; Carrafiello G
Radiol Med; 2013 Sep; 118(6):949-61. PubMed ID: 23892957
[TBL] [Abstract][Full Text] [Related]
49. Survival benefits of computed tomography-guided thermal ablation for adrenal metastases from hepatocellular carcinoma.
Lyu N; Kong Y; Pan T; Mu L; Sun X; Li S; Deng H; Lai J; Zhao M
Int J Hyperthermia; 2019; 36(1):1003-1011. PubMed ID: 31544545
[No Abstract] [Full Text] [Related]
50. Image-guided radiofrequency ablation of liver malignancies: experience at Singapore General Hospital.
Low SC; Lo RH; Lau TN; Ooi LL; Ho CK; Tan BS; Chung AY; Koo WH; Chow PK
Ann Acad Med Singap; 2006 Dec; 35(12):851-7. PubMed ID: 17218995
[TBL] [Abstract][Full Text] [Related]
51. Radiofrequency ablation for the treatment of liver tumors in the caudate lobe.
Seror O; Haddar D; N'Kontchou G; Ajavon Y; Trinchet JC; Beaugrand M; Sellier N
J Vasc Interv Radiol; 2005 Jul; 16(7):981-90. PubMed ID: 16002506
[TBL] [Abstract][Full Text] [Related]
52. Treatment outcomes of percutaneous radiofrequency ablation versus adrenalectomy for adrenal metastases: a retrospective comparative study.
Liu B; Mo C; Wang W; Ye J; Jiang C; Xie X; Huang J; Huang G; Long H; Xie X
J Endocrinol Invest; 2020 Sep; 43(9):1249-1257. PubMed ID: 32166699
[TBL] [Abstract][Full Text] [Related]
53. Diagnostic performance of contrast-enhanced computed tomography in the immediate assessment of radiofrequency ablation success in colorectal liver metastases.
Schraml C; Clasen S; Schwenzer NF; Koenigsrainer I; Herberts T; Claussen CD; Pereira PL
Abdom Imaging; 2008; 33(6):643-51. PubMed ID: 18175165
[TBL] [Abstract][Full Text] [Related]
54. MR-guided radiofrequency ablation using a wide-bore 1.5-T MR system: clinical results of 213 treated liver lesions.
Rempp H; Waibel L; Hoffmann R; Claussen CD; Pereira PL; Clasen S
Eur Radiol; 2012 Sep; 22(9):1972-82. PubMed ID: 22527377
[TBL] [Abstract][Full Text] [Related]
55. Metastases but not cardiovascular mortality reduces life expectancy following surgical resection of apparently benign pheochromocytoma.
Timmers HJ; Brouwers FM; Hermus AR; Sweep FC; Verhofstad AA; Verbeek AL; Pacak K; Lenders JW
Endocr Relat Cancer; 2008 Dec; 15(4):1127-33. PubMed ID: 18824558
[TBL] [Abstract][Full Text] [Related]
56. Computed Tomography-guided Cryoablation for Adrenal Pheochromocytoma: Safety and Clinical Effectiveness.
Zhang W; Shi YB; Zhuang ZX; Wang JP; Sun LJ; Fu YF
Surg Laparosc Endosc Percutan Tech; 2019 Oct; 29(5):409-412. PubMed ID: 31107857
[TBL] [Abstract][Full Text] [Related]
57. Percutaneous osteoplasty for hypervascular bone metastasis.
Shinoto M; Hasuo K; Aibe H; Shida Y; Kinjo M; Kubo Y; Terashima K
Radiat Med; 2008 Dec; 26(10):603-8. PubMed ID: 19132491
[TBL] [Abstract][Full Text] [Related]
58. Can tumor coverage evaluated 24 h post-radiofrequency ablation predict local tumor progression of liver metastases?
Vandenbroucke F; Vandemeulebroucke J; Buls N; Thoeni RF; de Mey J
Int J Comput Assist Radiol Surg; 2018 Dec; 13(12):1981-1989. PubMed ID: 29651715
[TBL] [Abstract][Full Text] [Related]
59. Fatty hepatocellular carcinoma: radiofrequency ablation--imaging findings.
Pupulim LF; Hakimé A; Barrau V; Abdel-Rehim M; Zappa M; Vilgrain V
Radiology; 2009 Mar; 250(3):940-8. PubMed ID: 19164699
[TBL] [Abstract][Full Text] [Related]
60. Radiofrequency ablation for treating liver metastases from a non-colorectal origin.
Yun BL; Lee JM; Baek JH; Kim SH; Lee JY; Han JK; Choi BI
Korean J Radiol; 2011; 12(5):579-87. PubMed ID: 21927559
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
